Constitutive Activation and Endocytosis of the Complement Factor 5a Receptor: Evidence for Multiple Activated Conformations of a G Protein‐Coupled Receptor
暂无分享,去创建一个
Elaine C Meng | E. Meng | H. Bourne | M. von Zastrow | T. Baranski | J. Whistler | Thomas J Baranski | B. Gerber | Henry R Bourne | Jennifer L. Whistler | Mark von Zastrow | Jennifer L Whistler | Basil O Gerber | Jennifer L. Whistler | Thomas J. Baranski | Henry R. Bourne
[1] E. Zuiderweg,et al. Identification of receptor-binding residues in the inflammatory complement protein C5a by site-directed mutagenesis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[2] J. Baldwin,et al. An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. , 1997, Journal of molecular biology.
[3] M. Caron,et al. A β-Arrestin/Green Fluorescent Protein Biosensor for Detecting G Protein-coupled Receptor Activation* , 1997, The Journal of Biological Chemistry.
[4] M. Caron,et al. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. , 1999, Science.
[5] J. Demartino,et al. Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[6] Marc Parmentier,et al. Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies. , 2002, Molecular biology of the cell.
[7] R. Lefkowitz,et al. Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. , 2000, Science.
[8] M. Caron,et al. Association of β-Arrestin with G Protein-coupled Receptors during Clathrin-mediated Endocytosis Dictates the Profile of Receptor Resensitization* , 1999, The Journal of Biological Chemistry.
[9] J. Whistler,et al. Morphine-activated opioid receptors elude desensitization by β-arrestin , 1998 .
[10] K. Palczewski,et al. Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.
[11] B. Kobilka,et al. Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changes. , 1995, The Journal of biological chemistry.
[12] L. Hunyady,et al. Identification of a cytoplasmic Ser-Thr-Leu motif that determines agonist-induced internalization of the AT1 angiotensin receptor. , 1994, The Journal of biological chemistry.
[13] M. von Zastrow,et al. Morphine-activated opioid receptors elude desensitization by beta-arrestin. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[14] M. Geffner,et al. Characterization of heterogeneous mutations causing constitutive activation of the luteinizing hormone receptor in familial male precocious puberty. , 1995, Human molecular genetics.
[15] N. Guex,et al. SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.
[16] J. Bockaert,et al. Molecular tinkering of G protein‐coupled receptors: an evolutionary success , 1999, The EMBO journal.
[17] M. Mayer,et al. Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones , 1984, Nature.
[18] J. Köhl,et al. Site-Directed Mutagenesis of Conserved Charged Residues in the Helical Region of the Human C5a Receptor , 1996 .
[19] F. Sánchez‐Madrid,et al. Similarities and Differences in RANTES- and (AOP)-RANTES–triggered Signals: Implications for Chemotaxis , 1999, The Journal of cell biology.
[20] J. Köhl,et al. Site-directed mutagenesis of conserved charged residues in the helical region of the human C5a receptor. Arg2O6 determines high-affinity binding sites of C5a receptor. , 1996, European journal of biochemistry.
[21] Gert Vriend,et al. GPCRDB information system for G protein-coupled receptors , 2003, Nucleic Acids Res..
[22] H. Burger. Selective Oestrogen Receptor Modulators , 2000, Hormone Research in Paediatrics.
[23] C. Strader,et al. Separation of the structural requirements for agonist-promoted activation and sequestration of the beta-adrenergic receptor. , 1990, Molecular pharmacology.
[24] M. Caron,et al. Cellular Trafficking of G Protein-coupled Receptor/β-Arrestin Endocytic Complexes* , 1999, The Journal of Biological Chemistry.
[25] M. Baggiolini,et al. The T cell chemokine receptor CCR7 is internalized on stimulation with ELC, but not with SLC , 2001, European journal of immunology.
[26] R. Lefkowitz,et al. A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. , 1993, The Journal of biological chemistry.
[27] Heidi E. Hamm,et al. The Many Faces of G Protein Signaling* , 1998, The Journal of Biological Chemistry.
[28] L. Nowak,et al. Magnesium gates glutamate-activated channels in mouse central neurones , 1984, Nature.
[29] Roland L. Dunbrack,et al. Prediction of protein side-chain rotamers from a backbone-dependent rotamer library: a new homology modeling tool. , 1997, Journal of molecular biology.
[30] T. Kenakin. Kenakin replies: Efficacy as the molecular property of a ligand , 1995 .
[31] T. Kenakin. Pharmacological proteus? , 1995, Trends in pharmacological sciences.
[32] H. Bourne,et al. Transducin‐alpha C‐terminal mutations prevent activation by rhodopsin: a new assay using recombinant proteins expressed in cultured cells. , 1995, The EMBO journal.
[33] L. Josefsson,et al. Evidence for kinship between diverse G-protein coupled receptors. , 1999, Gene.
[34] T. Schwartz,et al. Is there a 'lock' for all agonist 'keys' in 7TM receptors? , 1996, Trends in pharmacological sciences.
[35] Christopher J. Evans,et al. Morphine Activates Opioid Receptors without Causing Their Rapid Internalization* , 1996, The Journal of Biological Chemistry.
[36] B. Corvilain,et al. Somatic and germline mutations of the TSH receptor and thyroid diseases , 2001, Clinical endocrinology.
[37] M. von Zastrow,et al. A Phosphorylation-regulated Brake Mechanism Controls the Initial Endocytosis of Opioid Receptors but Is Not Required for Post-endocytic Sorting to Lysosomes* , 2001, The Journal of Biological Chemistry.
[38] P. Leff,et al. A three-state receptor model of agonist action. , 1997, Trends in pharmacological sciences.
[39] R Seifert,et al. Effects of guanine, inosine, and xanthine nucleotides on beta(2)-adrenergic receptor/G(s) interactions: evidence for multiple receptor conformations. , 1999, Molecular pharmacology.
[40] H. Bourne,et al. How receptors talk to trimeric G proteins. , 1997, Current opinion in cell biology.
[41] David A. Agard,et al. The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen , 1998, Cell.
[42] J. Benovic,et al. β-Arrestin acts as a clathrin adaptor in endocytosis of the β2-adrenergic receptor , 1996, Nature.
[43] J. R. Erickson,et al. Edg-2/Vzg-1 Couples to the Yeast Pheromone Response Pathway Selectively in Response to Lysophosphatidic Acid* , 1998, The Journal of Biological Chemistry.
[44] W. Lim,et al. Integration of multiple signals through cooperative regulation of the N-WASP-Arp2/3 complex. , 2000, Science.
[45] J. Benovic,et al. Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. , 1996, Nature.
[46] H. Brühl,et al. Differential Activation of CC Chemokine Receptors by AOP-RANTES* , 2000, The Journal of Biological Chemistry.
[47] B. Ozenberger,et al. Functional coupling of a mammalian somatostatin receptor to the yeast pheromone response pathway , 1995, Molecular and cellular biology.
[48] M. Caron,et al. Constitutive arrestin-mediated desensitization of a human vasopressin receptor mutant associated with nephrogenic diabetes insipidus. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[49] B. J. Knoll,et al. Partial agonists and G protein-coupled receptor desensitization. , 1999, Trends in pharmacological sciences.
[50] M. Pausch,et al. Pharmacological characterization of the rat A2a adenosine receptor functionally coupled to the yeast pheromone response pathway. , 1996, Molecular pharmacology.
[51] E. Prossnitz,et al. Arrestin Binding to the G Protein-coupled N-Formyl Peptide Receptor Is Regulated by the Conserved “DRY” Sequence* , 2000, The Journal of Biological Chemistry.
[52] P. Murphy. The molecular biology of leukocyte chemoattractant receptors. , 1994, Annual review of immunology.
[53] U. Gether. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. , 2000, Endocrine reviews.
[54] L. Jan,et al. Functional Dissociation of μ Opioid Receptor Signaling and Endocytosis Implications for the Biology of Opiate Tolerance and Addiction , 1999, Neuron.